TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

TRIAX PHARMS

Pharmaceuticals
Specialty

TRIAX PHARMS is a specialty pharmaceutical company with 2 FDA-approved products.

1971
Since
2
Drugs
-
Trials
24
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

MINOCYCLINE HYDROCHLORIDE 2025-10-10
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-08-01
Labeling
MINOCIN 2025-03-31
Labeling
MINOCIN 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
MINOCYCLINE HYDROCHLORIDE 2025-03-31
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...